Antharis Therapeutics, Inc.
Antharis Therapeutics is a multinational biopharmaceutical company developing new, cutting-edge treatments for cancer.
18 employees · est. 2020 · San Diego, United States
Arch Oncology is the older company (2020 vs 2006); Antharis Therapeutics, Inc. is the larger of the two.
Side-by-Side Comparison
| Metric | Antharis Therapeutics, Inc. | Arch Oncology |
|---|---|---|
| Founded | ||
| Founded | 2020 | 2006 older |
| Headquarters | ||
| Headquarters | San Diego, United States | Brisbane, United States |
| Employees | ||
| Employees | 18 larger | 7 |
| Industry | ||
| Industry | Biopharma, Biotechnology, Health and Wellness | Biotechnology, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Not tracked yet | Series C |
| Total Funding | ||
| Total Funding | Not tracked yet | $250.40M |
| Funding Rounds | ||
| Funding Rounds | Not tracked yet | 5 |
| Services | ||
| Services | Developing Transformative Medicines, Therapies Harnessing the Immune System, Cutting-edge Biomedical Research, Therapeutically-relevant Antibody Development | Not tracked yet |
| Target Customers | ||
| Target Customers | Healthcare Professionals, Patients with Unmet Medical Needs, Cancer Patients, Medical Institutions, Biotech and Pharmaceutical Partners | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Biopharmaceutical, Cancer Treatment, Monoclonal Antibodies, Antibody-drug Conjugates, Oncology, Therapeutic Antibodies, Inflammatory Diseases, Innovative Therapies, Biotech Acquisitions, Clinical Trials, Transformational Therapies, Unmet Medical Needs, Pioneering Research, Solid Tumor Therapy, Bispecific Antibodies | Immuno-oncology, Antibody Therapies, Clinical-stage, Phase 1/2 Trials, Solid Tumors, Hematologic Malignancies, Anti-CD47 Antibodies, Cancer Treatment, Drug Development, Macrophages, St. Louis, MO, Brisbane, CA, Tumor Microenvironment, Scientific Research |
| Website | ||
| Website | antharistherapeutics.com | archoncology.com |
About Antharis Therapeutics, Inc.
Antharis Therapeutics, Inc., founded in 2020 by Dr. Raphael R Pinaud, is a multinational biopharmaceutical company headquartered in the United States. Specializing in cancer and inflammatory disease treatments, it employs cutting-edge science to create next-generation monoclonal antibodies and antib...
About Arch Oncology
Arch Oncology is a biotechnology company founded in 2006 and based in the United States. The company is primarily focused on developing groundbreaking antibody therapies for the treatment of solid tumors and hematologic malignancies. Their lead product candidate AO-176 is currently in Phase 1/2 clin...
We will tell you when either one moves
BounceWatch watches Antharis Therapeutics, Inc. and Arch Oncology for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Antharis Therapeutics,... and Arch Oncology — by email.
Frequently Asked Questions
Compare Antharis Therapeutics, Inc. with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Antharis Therapeutics, Inc. on 27 Nov 2025, and Arch Oncology on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.